| 40:35.0.1.1.1 | PART 790
| PART 790 - PROCEDURES GOVERNING TESTING CONSENT AGREEMENTS AND TEST RULES | |
| 40:35.0.1.1.1.1 | SUBPART A
| Subpart A - General Provisions | |
| 40:35.0.1.1.1.1.1.1 | SECTION 790.1
| 790.1 Scope, purpose, and authority. | |
| 40:35.0.1.1.1.1.1.2 | SECTION 790.2
| 790.2 Applicability. | |
| 40:35.0.1.1.1.1.1.3 | SECTION 790.3
| 790.3 Definitions. | |
| 40:35.0.1.1.1.1.1.4 | SECTION 790.5
| 790.5 Submission of information. | |
| 40:35.0.1.1.1.1.1.5 | SECTION 790.7
| 790.7 Confidentiality. | |
| 40:35.0.1.1.1.2 | SUBPART B
| Subpart B - Procedures for Developing Consent Agreements and Test Rules | |
| 40:35.0.1.1.1.2.1.1 | SECTION 790.20
| 790.20 Recommendation, recommendation with an intent to designate, and designation of testing candidates by the ITC. | |
| 40:35.0.1.1.1.2.1.2 | SECTION 790.22
| 790.22 Procedures for developing consent agreements. | |
| 40:35.0.1.1.1.3 | SUBPART C
| Subpart C - Implementation, Enforcement, and Modification of Test Rules | |
| 40:35.0.1.1.1.3.1.1 | SECTION 790.40
| 790.40 Promulgation of test rules. | |
| 40:35.0.1.1.1.3.1.2 | SECTION 790.42
| 790.42 Persons subject to a test rule. | |
| 40:35.0.1.1.1.3.1.3 | SECTION 790.45
| 790.45 Submission of letter of intent to conduct testing or exemption application. | |
| 40:35.0.1.1.1.3.1.4 | SECTION 790.48
| 790.48 Procedure if no one submits a letter of intent to conduct testing. | |
| 40:35.0.1.1.1.3.1.5 | SECTION 790.50
| 790.50 Submission of study plans. | |
| 40:35.0.1.1.1.3.1.6 | SECTION 790.52
| 790.52 Phase II test rule. | |
| 40:35.0.1.1.1.3.1.7 | SECTION 790.55
| 790.55 Modification of test standards or schedules during conduct of test. | |
| 40:35.0.1.1.1.3.1.8 | SECTION 790.59
| 790.59 Failure to comply with a test rule. | |
| 40:35.0.1.1.1.4 | SUBPART D
| Subpart D - Implementation, Enforcement and Modification of Consent Agreements | |
| 40:35.0.1.1.1.4.1.1 | SECTION 790.60
| 790.60 Contents of consent agreements. | |
| 40:35.0.1.1.1.4.1.2 | SECTION 790.62
| 790.62 Submission of study plans and conduct of testing. | |
| 40:35.0.1.1.1.4.1.3 | SECTION 790.65
| 790.65 Failure to comply with a consent agreement. | |
| 40:35.0.1.1.1.4.1.4 | SECTION 790.68
| 790.68 Modification of consent agreements. | |
| 40:35.0.1.1.1.5 | SUBPART E
| Subpart E - Exemptions From Test Rules | |
| 40:35.0.1.1.1.5.1.1 | SECTION 790.80
| 790.80 Submission of exemption applications. | |
| 40:35.0.1.1.1.5.1.2 | SECTION 790.82
| 790.82 Content of exemption application. | |
| 40:35.0.1.1.1.5.1.3 | SECTION 790.85
| 790.85 Submission of equivalence data. | |
| 40:35.0.1.1.1.5.1.4 | SECTION 790.87
| 790.87 Approval of exemption applications. | |
| 40:35.0.1.1.1.5.1.5 | SECTION 790.88
| 790.88 Denial of exemption application. | |
| 40:35.0.1.1.1.5.1.6 | SECTION 790.90
| 790.90 Appeal of denial of exemption application. | |
| 40:35.0.1.1.1.5.1.7 | SECTION 790.93
| 790.93 Termination of conditional exemption. | |
| 40:35.0.1.1.1.5.1.8 | SECTION 790.97
| 790.97 Hearing procedures. | |
| 40:35.0.1.1.1.5.1.9 | SECTION 790.99
| 790.99 Statement of financial responsibility. | |
| 40:35.0.1.1.2 | PART 791
| PART 791 - DATA REIMBURSEMENT | |
| 40:35.0.1.1.2.1 | SUBPART A
| Subpart A - General Provisions | |
| 40:35.0.1.1.2.1.1.1 | SECTION 791.1
| 791.1 Scope and authority. | |
| 40:35.0.1.1.2.1.1.2 | SECTION 791.2
| 791.2 Applicability. | |
| 40:35.0.1.1.2.1.1.3 | SECTION 791.3
| 791.3 Definitions. | |
| 40:35.0.1.1.2.2 | SUBPART B
| Subpart B - Hearing Procedures | |
| 40:35.0.1.1.2.2.1.1 | SECTION 791.20
| 791.20 Initiation of reimbursement proceeding. | |
| 40:35.0.1.1.2.2.1.2 | SECTION 791.22
| 791.22 Consolidation of hearings. | |
| 40:35.0.1.1.2.2.1.3 | SECTION 791.27
| 791.27 Pre-hearing preparation. | |
| 40:35.0.1.1.2.2.1.4 | SECTION 791.29
| 791.29 Appointment of hearing officer. | |
| 40:35.0.1.1.2.2.1.5 | SECTION 791.30
| 791.30 Hearing procedures. | |
| 40:35.0.1.1.2.2.1.6 | SECTION 791.31
| 791.31 Expedited procedures. | |
| 40:35.0.1.1.2.2.1.7 | SECTION 791.34
| 791.34 Serving of notice. | |
| 40:35.0.1.1.2.2.1.8 | SECTION 791.37
| 791.37 The award. | |
| 40:35.0.1.1.2.2.1.9 | SECTION 791.39
| 791.39 Fees and expenses. | |
| 40:35.0.1.1.2.3 | SUBPART C
| Subpart C - Basis for Proposed Order | |
| 40:35.0.1.1.2.3.1.1 | SECTION 791.40
| 791.40 Basis for the proposed order. | |
| 40:35.0.1.1.2.3.1.2 | SECTION 791.45
| 791.45 Processors. | |
| 40:35.0.1.1.2.3.1.3 | SECTION 791.48
| 791.48 Production volume. | |
| 40:35.0.1.1.2.3.1.4 | SECTION 791.50
| 791.50 Costs. | |
| 40:35.0.1.1.2.3.1.5 | SECTION 791.52
| 791.52 Multiple tests. | |
| 40:35.0.1.1.2.4 | SUBPART D
| Subpart D - Review | |
| 40:35.0.1.1.2.4.1.1 | SECTION 791.60
| 791.60 Review. | |
| 40:35.0.1.1.2.5 | SUBPART E
| Subpart E - Final Order | |
| 40:35.0.1.1.2.5.1.1 | SECTION 791.85
| 791.85 Availability of final Agency order. | |
| 40:35.0.1.1.2.6 | SUBPART F
| Subpart F - Prohibited Acts | |
| 40:35.0.1.1.2.6.1.1 | SECTION 791.105
| 791.105 Prohibited acts. | |
| 40:35.0.1.1.3 | PART 792
| PART 792 - GOOD LABORATORY PRACTICE STANDARDS | |
| 40:35.0.1.1.3.1 | SUBPART A
| Subpart A - General Provisions | |
| 40:35.0.1.1.3.1.1.1 | SECTION 792.1
| 792.1 Scope. | |
| 40:35.0.1.1.3.1.1.2 | SECTION 792.3
| 792.3 Definitions. | |
| 40:35.0.1.1.3.1.1.3 | SECTION 792.10
| 792.10 Applicability to studies performed under grants and contracts. | |
| 40:35.0.1.1.3.1.1.4 | SECTION 792.12
| 792.12 Statement of compliance or non-compliance. | |
| 40:35.0.1.1.3.1.1.5 | SECTION 792.15
| 792.15 Inspection of a testing facility. | |
| 40:35.0.1.1.3.1.1.6 | SECTION 792.17
| 792.17 Effects of non-compliance. | |
| 40:35.0.1.1.3.2 | SUBPART B
| Subpart B - Organization and Personnel | |
| 40:35.0.1.1.3.2.1.1 | SECTION 792.29
| 792.29 Personnel. | |
| 40:35.0.1.1.3.2.1.2 | SECTION 792.31
| 792.31 Testing facility management. | |
| 40:35.0.1.1.3.2.1.3 | SECTION 792.33
| 792.33 Study director. | |
| 40:35.0.1.1.3.2.1.4 | SECTION 792.35
| 792.35 Quality assurance unit. | |
| 40:35.0.1.1.3.3 | SUBPART C
| Subpart C - Facilities | |
| 40:35.0.1.1.3.3.1.1 | SECTION 792.41
| 792.41 General. | |
| 40:35.0.1.1.3.3.1.2 | SECTION 792.43
| 792.43 Test system care facilities. | |
| 40:35.0.1.1.3.3.1.3 | SECTION 792.45
| 792.45 Test system supply facilities. | |
| 40:35.0.1.1.3.3.1.4 | SECTION 792.47
| 792.47 Facilities for handling test, control, and reference substances. | |
| 40:35.0.1.1.3.3.1.5 | SECTION 792.49
| 792.49 Laboratory operation areas. | |
| 40:35.0.1.1.3.3.1.6 | SECTION 792.51
| 792.51 Specimen and data storage facilities. | |
| 40:35.0.1.1.3.4 | SUBPART D
| Subpart D - Equipment | |
| 40:35.0.1.1.3.4.1.1 | SECTION 792.61
| 792.61 Equipment design. | |
| 40:35.0.1.1.3.4.1.2 | SECTION 792.63
| 792.63 Maintenance and calibration of equipment. | |
| 40:35.0.1.1.3.5 | SUBPART E
| Subpart E - Testing Facilities Operation | |
| 40:35.0.1.1.3.5.1.1 | SECTION 792.81
| 792.81 Standard operating procedures. | |
| 40:35.0.1.1.3.5.1.2 | SECTION 792.83
| 792.83 Reagents and solutions. | |
| 40:35.0.1.1.3.5.1.3 | SECTION 792.90
| 792.90 Animal and other test system care. | |
| 40:35.0.1.1.3.6 | SUBPART F
| Subpart F - Test, Control, and Reference Substances | |
| 40:35.0.1.1.3.6.1.1 | SECTION 792.105
| 792.105 Test, control, and reference substance characterization. | |
| 40:35.0.1.1.3.6.1.2 | SECTION 792.107
| 792.107 Test, control, and reference substance handling. | |
| 40:35.0.1.1.3.6.1.3 | SECTION 792.113
| 792.113 Mixtures of substances with carriers. | |
| 40:35.0.1.1.3.7 | SUBPART G
| Subpart G - Protocol for and Conduct of A Study | |
| 40:35.0.1.1.3.7.1.1 | SECTION 792.120
| 792.120 Protocol. | |
| 40:35.0.1.1.3.7.1.2 | SECTION 792.130
| 792.130 Conduct of a study. | |
| 40:35.0.1.1.3.7.1.3 | SECTION 792.135
| 792.135 Physical and chemical characterization studies. | |
| 40:35.0.1.1.3.8 | SUBPART H
| Subparts H-I [Reserved] | |
| 40:35.0.1.1.3.9 | SUBPART J
| Subpart J - Records and Reports | |
| 40:35.0.1.1.3.9.1.1 | SECTION 792.185
| 792.185 Reporting of study results. | |
| 40:35.0.1.1.3.9.1.2 | SECTION 792.190
| 792.190 Storage and retrieval of records and data. | |
| 40:35.0.1.1.3.9.1.3 | SECTION 792.195
| 792.195 Retention of records. | |
| 40:35.0.1.1.4 | PART 795
| PART 795 - PROVISIONAL TEST GUIDELINES | |
| 40:35.0.1.1.4.1 | SUBPART A
| Subpart A [Reserved] | |
| 40:35.0.1.1.4.2 | SUBPART B
| Subpart B - Provisional Chemical Fate Guidelines | |
| 40:35.0.1.1.4.2.1.1 | SECTION 795.70
| 795.70 Indirect photolysis screening test: Sunlight photolysis in waters containing dissolved humic substances. | |
| 40:35.0.1.1.4.3 | SUBPART C
| Subpart C - Provisional Environmental Effects Guidelines | |
| 40:35.0.1.1.4.3.1.1 | SECTION 795.120
| 795.120 Gammarid acute toxicity test. | |
| 40:35.0.1.1.4.4 | SUBPART D
| Subpart D - Provisional Health Effects Guidelines | |
| 40:35.0.1.1.4.4.1.1 | SECTION 795.225
| 795.225 Dermal pharmacokinetics of DGBE and DGBA. | |
| 40:35.0.1.1.4.4.1.2 | SECTION 795.228
| 795.228 Oral/dermal pharmacokinetics. | |
| 40:35.0.1.1.4.4.1.3 | SECTION 795.231
| 795.231 Pharmacokinetics of isopropanal. | |
| 40:35.0.1.1.4.4.1.4 | SECTION 795.232
| 795.232 Inhalation and dermal pharmacokinetics of commercial hexane. | |
| 40:35.0.1.1.4.4.1.5 | SECTION 795.250
| 795.250 Developmental neurotoxicity screen. | |
| 40:35.0.1.1.5 | PART 796
| PART 796 - CHEMICAL FATE TESTING GUIDELINES | |
| 40:35.0.1.1.5.1 | SUBPART A
| Subpart A [Reserved] | |
| 40:35.0.1.1.5.2 | SUBPART B
| Subpart B - Physical and Chemical Properties | |
| 40:35.0.1.1.5.2.1.1 | SECTION 796.1050
| 796.1050 Absorption in aqueous solution: Ultraviolet/visible spectra. | |
| 40:35.0.1.1.5.2.1.2 | SECTION 796.1950
| 796.1950 Vapor pressure. | |
| 40:35.0.1.1.5.3 | SUBPART C
| Subpart C - Transport Processes | |
| 40:35.0.1.1.5.3.1.1 | SECTION 796.2750
| 796.2750 Sediment and soil adsorption isotherm. | |
| 40:35.0.1.1.5.4 | SUBPART D
| Subpart D - Transformation Processes | |
| 40:35.0.1.1.5.4.1.1 | SECTION 796.3100
| 796.3100 Aerobic aquatic biodegradation. | |
| 40:35.0.1.1.5.4.1.2 | SECTION 796.3500
| 796.3500 Hydrolysis as a function of pH at 25 °C. | |
| 40:35.0.1.1.6 | PART 797
| PART 797 - ENVIRONMENTAL EFFECTS TESTING GUIDELINES | |
| 40:35.0.1.1.6.1 | SUBPART A
| Subpart A [Reserved] | |
| 40:35.0.1.1.6.2 | SUBPART B
| Subpart B - Aquatic Guidelines | |
| 40:35.0.1.1.6.2.1.1 | SECTION 797.1050
| 797.1050 Algal acute toxicity test. | |
| 40:35.0.1.1.6.2.1.2 | SECTION 797.1300
| 797.1300 Daphnid acute toxicity test. | |
| 40:35.0.1.1.6.2.1.3 | SECTION 797.1330
| 797.1330 Daphnid chronic toxicity test. | |
| 40:35.0.1.1.6.2.1.4 | SECTION 797.1400
| 797.1400 Fish acute toxicity test. | |
| 40:35.0.1.1.6.2.1.5 | SECTION 797.1600
| 797.1600 Fish early life stage toxicity test. | |
| 40:35.0.1.1.6.2.1.6 | SECTION 797.1930
| 797.1930 Mysid shrimp acute toxicity test. | |
| 40:35.0.1.1.6.2.1.7 | SECTION 797.1950
| 797.1950 Mysid shrimp chronic toxicity test. | |
| 40:35.0.1.1.7 | PART 798
| PART 798 - HEALTH EFFECTS TESTING GUIDELINES | |
| 40:35.0.1.1.7.1 | SUBPART A
| Subparts A-B [Reserved] | |
| 40:35.0.1.1.7.2 | SUBPART C
| Subpart C - Subchronic Exposure | |
| 40:35.0.1.1.7.2.1.1 | SECTION 798.2250
| 798.2250 Dermal toxicity. | |
| 40:35.0.1.1.7.2.1.2 | SECTION 798.2450
| 798.2450 Inhalation toxicity. | |
| 40:35.0.1.1.7.2.1.3 | SECTION 798.2650
| 798.2650 Oral toxicity. | |
| 40:35.0.1.1.7.3 | SUBPART D
| Subpart D - Chronic Exposure | |
| 40:35.0.1.1.7.3.1.1 | SECTION 798.3260
| 798.3260 Chronic toxicity. | |
| 40:35.0.1.1.7.3.1.2 | SECTION 798.3300
| 798.3300 Oncogenicity. | |
| 40:35.0.1.1.7.3.1.3 | SECTION 798.3320
| 798.3320 Combined chronic toxicity/oncogenicity. | |
| 40:35.0.1.1.7.4 | SUBPART E
| Subpart E - Specific Organ/Tissue Toxicity | |
| 40:35.0.1.1.7.4.1.1 | SECTION 798.4100
| 798.4100 Dermal sensitization. | |
| 40:35.0.1.1.7.4.1.2 | SECTION 798.4350
| 798.4350 Inhalation developmental toxicity study. | |
| 40:35.0.1.1.7.4.1.3 | SECTION 798.4700
| 798.4700 Reproduction and fertility effects. | |
| 40:35.0.1.1.7.4.1.4 | SECTION 798.4900
| 798.4900 Developmental toxicity study. | |
| 40:35.0.1.1.7.5 | SUBPART F
| Subpart F - Genetic Toxicity | |
| 40:35.0.1.1.7.5.1.1 | SECTION 798.5195
| 798.5195 Mouse biochemical specific locus test. | |
| 40:35.0.1.1.7.5.1.2 | SECTION 798.5200
| 798.5200 Mouse visible specific locus test. | |
| 40:35.0.1.1.7.5.1.3 | SECTION 798.5265
| 798.5265 The salmonella typhimurium reverse mutation assay. | |
| 40:35.0.1.1.7.5.1.4 | SECTION 798.5275
| 798.5275 Sex-linked recessive lethal test in drosophila melanogaster. | |
| 40:35.0.1.1.7.5.1.5 | SECTION 798.5300
| 798.5300 Detection of gene mutations in somatic cells in culture. | |
| 40:35.0.1.1.7.5.1.6 | SECTION 798.5375
| 798.5375 In vitro mammalian cytogenetics. | |
| 40:35.0.1.1.7.5.1.7 | SECTION 798.5385
| 798.5385 In vivo mammalian bone marrow cytogenetics tests: Chromosomal analysis. | |
| 40:35.0.1.1.7.5.1.8 | SECTION 798.5395
| 798.5395 In vivo mammalian bone marrow cytogenetics tests: Micronucleus assay. | |
| 40:35.0.1.1.7.5.1.9 | SECTION 798.5450
| 798.5450 Rodent dominant lethal assay. | |
| 40:35.0.1.1.7.5.1.10 | SECTION 798.5460
| 798.5460 Rodent heritable translocation assays. | |
| 40:35.0.1.1.7.5.1.11 | SECTION 798.5500
| 798.5500 Differential growth inhibition of repair proficient and repair deficient bacteria: “Bacterial DNA damage or repair tests.” | |
| 40:35.0.1.1.7.5.1.12 | SECTION 798.5955
| 798.5955 Heritable translocation test in drosophila melanogaster. | |
| 40:35.0.1.1.7.6 | SUBPART G
| Subpart G - Neurotoxicity | |
| 40:35.0.1.1.7.6.1.1 | SECTION 798.6050
| 798.6050 Functional observational battery. | |
| 40:35.0.1.1.7.6.1.2 | SECTION 798.6200
| 798.6200 Motor activity. | |
| 40:35.0.1.1.7.6.1.3 | SECTION 798.6400
| 798.6400 Neuropathology. | |
| 40:35.0.1.1.7.6.1.4 | SECTION 798.6500
| 798.6500 Schedule-controlled operant behavior. | |
| 40:35.0.1.1.7.6.1.5 | SECTION 798.6560
| 798.6560 Subchronic delayed neuro-toxicity of organophosphorus substances. | |
| 40:35.0.1.1.8 | PART 799
| PART 799 - IDENTIFICATION OF SPECIFIC CHEMICAL SUBSTANCE AND MIXTURE TESTING REQUIREMENTS | |
| 40:35.0.1.1.8.1 | SUBPART A
| Subpart A - General Provisions | |
| 40:35.0.1.1.8.1.1.1 | SECTION 799.1
| 799.1 Scope and purpose. | |
| 40:35.0.1.1.8.1.1.2 | SECTION 799.2
| 799.2 Applicability. | |
| 40:35.0.1.1.8.1.1.3 | SECTION 799.3
| 799.3 Definitions. | |
| 40:35.0.1.1.8.1.1.4 | SECTION 799.5
| 799.5 Submission of information. | |
| 40:35.0.1.1.8.1.1.5 | SECTION 799.10
| 799.10 Test standards. | |
| 40:35.0.1.1.8.1.1.6 | SECTION 799.11
| 799.11 Availability of test guidelines. | |
| 40:35.0.1.1.8.1.1.7 | SECTION 799.12
| 799.12 Test results. | |
| 40:35.0.1.1.8.1.1.8 | SECTION 799.17
| 799.17 Effects of non-compliance. | |
| 40:35.0.1.1.8.1.1.9 | SECTION 799.18
| 799.18 Chemicals subject of test rules or consent orders for which the testing reimbursement period has passed. | |
| 40:35.0.1.1.8.1.1.10 | SECTION 799.19
| 799.19 Chemical imports and exports. | |
| 40:35.0.1.1.8.2 | SUBPART B
| Subpart B - Specific Chemical Test Rules | |
| 40:35.0.1.1.8.2.1.1 | SECTION 799.1053
| 799.1053 Trichlorobenzenes. | |
| 40:35.0.1.1.8.2.1.2 | SECTION 799.1560
| 799.1560 Diethylene glycol butyl ether and diethylene glycol butyl ether acetate. | |
| 40:35.0.1.1.8.2.1.3 | SECTION 799.1575
| 799.1575 Diethylenetriamine (DETA). | |
| 40:35.0.1.1.8.2.1.4 | SECTION 799.1645
| 799.1645 2-Ethylhexanol. | |
| 40:35.0.1.1.8.2.1.5 | SECTION 799.1700
| 799.1700 Fluoroalkenes. | |
| 40:35.0.1.1.8.2.1.6 | SECTION 799.2155
| 799.2155 Commercial hexane. | |
| 40:35.0.1.1.8.2.1.7 | SECTION 799.2325
| 799.2325 Isopropanol. | |
| 40:35.0.1.1.8.2.1.8 | SECTION 799.2475
| 799.2475 2-Mercaptobenzothiazole. | |
| 40:35.0.1.1.8.2.1.9 | SECTION 799.2700
| 799.2700 Methyl ethyl ketoxime. | |
| 40:35.0.1.1.8.2.1.10 | SECTION 799.3300
| 799.3300 Unsubstituted phenylenediamines. | |
| 40:35.0.1.1.8.2.1.11 | SECTION 799.4360
| 799.4360 Tributyl phosphate. | |
| 40:35.0.1.1.8.2.1.12 | SECTION 799.4440
| 799.4440 Triethylene glycol monomethyl ether. | |
| 40:35.0.1.1.8.3 | SUBPART C
| Subpart C - Testing Consent Orders | |
| 40:35.0.1.1.8.3.1.1 | SECTION 799.5000
| 799.5000 Testing consent orders for substances and mixtures with Chemical Abstract Service Registry Numbers. | |
| 40:35.0.1.1.8.3.1.2 | SECTION 799.5025
| 799.5025 Testing consent orders for mixtures without Chemical Abstracts Service Registry Numbers. | |
| 40:35.0.1.1.8.4 | SUBPART D
| Subpart D - Multichemical Test Rules | |
| 40:35.0.1.1.8.4.1.1 | SECTION 799.5055
| 799.5055 Hazardous waste constituents subject to testing. | |
| 40:35.0.1.1.8.4.1.2 | SECTION 799.5075
| 799.5075 Drinking water contaminants subject to testing. | |
| 40:35.0.1.1.8.4.1.3 | SECTION 799.5085
| 799.5085 Chemical testing requirements for first group of high production volume chemicals (HPV1). | |
| 40:35.0.1.1.8.4.1.4 | SECTION 799.5087
| 799.5087 Chemical testing requirements for second group of high production volume chemicals (HPV2). | |
| 40:35.0.1.1.8.4.1.5 | SECTION 799.5089
| 799.5089 Chemical testing requirements for third group of high production volume chemicals (HPV3). | |
| 40:35.0.1.1.8.4.1.6 | SECTION 799.5115
| 799.5115 Chemical testing requirements for certain chemicals of interest to the Occupational Safety and Health Administration. | |
| 40:35.0.1.1.8.5 | SUBPART E
| Subpart E - Product Properties Test Guidelines | |
| 40:35.0.1.1.8.5.1.1 | SECTION 799.6755
| 799.6755 TSCA partition coefficient (n-octanol/water), shake flask method. | |
| 40:35.0.1.1.8.5.1.2 | SECTION 799.6756
| 799.6756 TSCA partition coefficient (n-octanol/water), generator column method. | |
| 40:35.0.1.1.8.5.1.3 | SECTION 799.6784
| 799.6784 TSCA water solubility: Column elution method; shake flask method. | |
| 40:35.0.1.1.8.5.1.4 | SECTION 799.6786
| 799.6786 TSCA water solubility: Generator column method. | |
| 40:35.0.1.1.8.6 | SUBPART F
| Subparts F-G [Reserved] | |
| 40:35.0.1.1.8.7 | SUBPART H
| Subpart H - Health Effects Test Guidelines | |
| 40:35.0.1.1.8.7.1.1 | SECTION 799.9110
| 799.9110 TSCA acute oral toxicity. | |
| 40:35.0.1.1.8.7.1.2 | SECTION 799.9120
| 799.9120 TSCA acute dermal toxicity. | |
| 40:35.0.1.1.8.7.1.3 | SECTION 799.9130
| 799.9130 TSCA acute inhalation toxicity. | |
| 40:35.0.1.1.8.7.1.4 | SECTION 799.9135
| 799.9135 TSCA acute inhalation toxicity with histopathology. | |
| 40:35.0.1.1.8.7.1.5 | SECTION 799.9305
| 799.9305 TSCA Repeated dose 28-day oral toxicity study in rodents. | |
| 40:35.0.1.1.8.7.1.6 | SECTION 799.9310
| 799.9310 TSCA 90-day oral toxicity in rodents. | |
| 40:35.0.1.1.8.7.1.7 | SECTION 799.9325
| 799.9325 TSCA 90-day dermal toxicity. | |
| 40:35.0.1.1.8.7.1.8 | SECTION 799.9346
| 799.9346 TSCA 90-day inhalation toxicity. | |
| 40:35.0.1.1.8.7.1.9 | SECTION 799.9355
| 799.9355 TSCA reproduction/developmental toxicity screening test. | |
| 40:35.0.1.1.8.7.1.10 | SECTION 799.9365
| 799.9365 TSCA combined repeated dose toxicity study with the reproduction/developmental toxicity screening test. | |
| 40:35.0.1.1.8.7.1.11 | SECTION 799.9370
| 799.9370 TSCA prenatal developmental toxicity. | |
| 40:35.0.1.1.8.7.1.12 | SECTION 799.9380
| 799.9380 TSCA reproduction and fertility effects. | |
| 40:35.0.1.1.8.7.1.13 | SECTION 799.9410
| 799.9410 TSCA chronic toxicity. | |
| 40:35.0.1.1.8.7.1.14 | SECTION 799.9420
| 799.9420 TSCA carcinogenicity. | |
| 40:35.0.1.1.8.7.1.15 | SECTION 799.9430
| 799.9430 TSCA combined chronic toxicity/carcinogenicity. | |
| 40:35.0.1.1.8.7.1.16 | SECTION 799.9510
| 799.9510 TSCA bacterial reverse mutation test. | |
| 40:35.0.1.1.8.7.1.17 | SECTION 799.9530
| 799.9530 TSCA in vitro mammalian cell gene mutation test. | |
| 40:35.0.1.1.8.7.1.18 | SECTION 799.9537
| 799.9537 TSCA in vitro mammalian chromosome aberration test. | |
| 40:35.0.1.1.8.7.1.19 | SECTION 799.9538
| 799.9538 TSCA mammalian bone marrow chromosomal aberration test. | |
| 40:35.0.1.1.8.7.1.20 | SECTION 799.9539
| 799.9539 TSCA mammalian erythrocyte micronucleus test. | |
| 40:35.0.1.1.8.7.1.21 | SECTION 799.9620
| 799.9620 TSCA neurotoxicity screening battery. | |
| 40:35.0.1.1.8.7.1.22 | SECTION 799.9630
| 799.9630 TSCA developmental neurotoxicity. | |
| 40:35.0.1.1.8.7.1.23 | SECTION 799.9748
| 799.9748 TSCA metabolism and pharmacokinetics | |
| 40:35.0.1.1.8.7.1.24 | SECTION 799.9780
| 799.9780 TSCA immunotoxicity. | |